Animal Health & Livestock Biotechnology Insurance
A laboratory technology can be acceptable in one end use and outside appetite when applied to livestock or the food chain. We lead with the end use so the market can assess it honestly.
Specialist
Market access
Hard-to-place
Our focus
Australia
National broking
Recognition
The Tank take
Animal-health and livestock biotechnology risks require early appetite testing. Insurers assess species, intended use, food-chain implications, trials, field release, product stage, claims, countries and who ultimately manufactures or supplies the output.
A technically strong laboratory risk can still fall outside an insurer's appetite because of its final animal or livestock application. Tank puts the end use in front of insurers from the outset - burying it wastes everyone's time and burns market goodwill.
The placement that proved the point
A start-up performed genomic analysis, phage characterisation and laboratory R&D with no commercial sales. Two specialist markets declined because the ultimate application was livestock health - the science was never the issue. We restructured the submission around laboratory R&D rather than consultancy, removed the PI that did not match the model, and preserved products-related and R&D extensions.
The result: Terms obtained from a specialist market subject to recourse and excluded-product review. The lesson: end use can drive appetite more than revenue stage or scientific quality.
Anonymised. Appetite for livestock and food-chain applications is a dated observation and moves with market conditions.
The end-use factors that move appetite
Companion animals, livestock and food-production applications carry different severity and aggregation concerns. Anything entering the human food chain multiplies the questions.
Animal studies, field trials, environmental release and on-farm use introduce additional participants, properties and jurisdictions beyond the laboratory.
Disease, herd loss, reduced productivity and failed performance can create substantial financial exposures - and efficacy claims in marketing can become contractual promises.
Research-only work, investigational use and commercial supply require different evidence and different wording. The transition points are where cover most often lags the business.
The questions an animal-biotech submission must answer
- 01
Which species, customers and ultimate end uses are involved?
- 02
Can the product enter the human food chain or the environment?
- 03
What laboratory, animal or field trials are performed?
- 04
Who owns regulatory, veterinary and product-supply responsibility?
- 05
What efficacy claims, exclusions and contractual warranties apply?
- 06
Which specialist markets accept this end use at present?
Related life sciences guides
Explore cover by business activity
Questions about Animal & Livestock Risks
It determines who or what can be harmed, the possible aggregation of losses and whether the risk falls within the insurer's current appetite. In one Tank placement, end use alone drove two declines before terms were found.
No. Some coverage concepts overlap, but species, veterinary, agricultural, food-chain and environmental exposures can differ materially, and so do the markets willing to write them.
Sometimes a market will quote other activities while excluding a particular product or end use. Whether that structure is commercially useful depends on how central the excluded product is to the business.
Potentially. Study contracts, animal welfare obligations, property, veterinary and product exposures should be mapped and disclosed before trials begin.
General information only. This page does not take account of your objectives, financial situation or needs and is not legal advice. Cover depends on the insurer, policy wording, limits, excesses, exclusions and information disclosed. Read the relevant policy documents and obtain professional advice before deciding.
Put your life sciences risk in front of the right markets
Tell us what you research, build, test, supply or operate, plus any overseas exposure. We will explain the available terms and exclusions before you decide.